SLC6A4 and central nervous system cancer: This serotonergic nuclei-dependent, circuit-specific effect on glioma cell proliferation was further validated using the aforementioned transgenic mouse model for optogenetic control of serotonergic neuronal activity (SERT-Cre+/wt × Ai230flx/wt).